These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 6531205)
1. [Flow-cytometric analysis of changes in lymphocyte subsets in the blood of cancer patients during radiation therapy]. Ogawa Y; Maeda T; Ogawa Y; Hamada F; Morita M; Yamamoto Y; Odani R; Yoshida S Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Dec; 44(12):1537-45. PubMed ID: 6531205 [No Abstract] [Full Text] [Related]
2. [Flow-cytometric analysis of changes in lymphocyte subsets in the blood of cancer patients during radiation therapy]. Ogawa Y; Maeda T; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1883-903. PubMed ID: 6672139 [No Abstract] [Full Text] [Related]
3. [Flow-cytometric analysis of changes of lymphocyte subsets in the blood of cancer patients during radiotherapy. 4. Special reference to OKT8+-lymphocytes]. Ogawa Y; Maeda T; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1041-8. PubMed ID: 6094691 [No Abstract] [Full Text] [Related]
4. [Changes in lymphocyte subsets in the peripheral blood of patients with lung cancer during radiotherapy--analysis with flow-cytometry. (1. On the total changes]. Inomata T; Ogawa Y; Maeda T Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1055-67. PubMed ID: 6334124 [No Abstract] [Full Text] [Related]
5. [Clinical application of a rapid flow-cytometric immunofluorescence method for studying lymphocyte subsets--changes during radiotherapy of cancer patients]. Ogawa Y; Maeda T; Inomata T; Ogawa Y; Morita M; Yamamoto Y; Okani R; Yoshida S Rinsho Hoshasen; 1984 Jan; 29(1):167-70. PubMed ID: 6737758 [No Abstract] [Full Text] [Related]
6. [Flow-cytometric analysis of change of OKT6+-lymphocytes in blood of cancer patients drug radiation therapy]. Ogawa Y; Maeda T; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S Nihon Gan Chiryo Gakkai Shi; 1983 Dec; 18(8):2072-8. PubMed ID: 6325563 [No Abstract] [Full Text] [Related]
7. [Flow-cytometric analysis of changes in lymphocyte subsets in the blood of cancer patients during radiotherapy. 1. Special reference to OKT11+-lymphocytes]. Ogawa Y; Maeda T; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S Nihon Gan Chiryo Gakkai Shi; 1984 Feb; 19(1):64-70. PubMed ID: 6549339 [No Abstract] [Full Text] [Related]
8. [Flow-cytometric analysis of changes of lymphocyte subsets in the blood in cancer patients during radiotherapy. 5. Special reference to OKIa 1+-lymphocytes]. Ogawa Y; Maeda T; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2138-45. PubMed ID: 6530582 [No Abstract] [Full Text] [Related]
9. [Flow-cytometric analysis of changes of lymphocyte subsets in the blood of cancer patients during radiotherapy. 6. Special reference to OKT3+-lymphocytes]. Ogawa Y; Maeda T; Ogawa Y; Hamada F; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2279-86. PubMed ID: 6549464 [No Abstract] [Full Text] [Related]
10. [Changes of lymphocyte subsets in peripheral blood and cancer tissue during radiotherapy--analysis with monoclonal antibodies]. Ogawa Y; Hamada F; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Maeda T Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Nov; 44(11):1417-9. PubMed ID: 6531200 [No Abstract] [Full Text] [Related]
11. [Changes in lymphocyte subsets in the peripheral blood of patients with lung cancer during radiotherapy--analysis with flow-cytometry. (2. On the changes with the effects of radiotherapy]. Inomata T; Ogawa Y; Maeda T Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1068-78. PubMed ID: 6334125 [No Abstract] [Full Text] [Related]
12. [Flow cytometric analysis of changes of OKT9+-lymphocytes in the blood of cancer patients during radiation therapy]. Ogawa Y; Maeda T; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S Rinsho Hoshasen; 1984 Mar; 29(3):387-92. PubMed ID: 6611427 [No Abstract] [Full Text] [Related]
13. [Flow-cytometric analysis of changes in lymphocyte subsets in the blood of cancer patients during radiotherapy. 9. Special reference to head and neck cancer patients]. Ogawa Y; Maeda T; Hamada F; Sawada A; Morita M; Yamamoto Y; Yoshida S; Saito H; Ono A; Ozaki T Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2279-85. PubMed ID: 3831172 [No Abstract] [Full Text] [Related]
14. [Flow cytometric analysis of changes in lymphocyte subsets in the blood of cancer patients during radiation therapy. 8. Special reference to OKT10+-lymphocytes]. Ogawa Y; Maeda T; Ogawa Y; Hamada F; Morita M; Yamamoto Y; Odani R; Yoshida S Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):542-9. PubMed ID: 3840515 [No Abstract] [Full Text] [Related]
15. [Influence of hemoglobin level, arterial oxygen partial pressure and arterial oxygen content on the results of radiation therapy in lung squamous cell cancer]. Sasai K; Ono K; Takahashi M; Abe M Gan No Rinsho; 1989 Oct; 35(13):1554-7. PubMed ID: 2585726 [TBL] [Abstract][Full Text] [Related]
16. Peripheral blood lymphocytes and their subpopulations in lung carcinoma. Zółtowska A; Skokowski J; Mlekodaj S; Boj E Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027 [TBL] [Abstract][Full Text] [Related]
17. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082 [TBL] [Abstract][Full Text] [Related]
18. [Haptoglobin system in lung cancer]. Ochmański W Folia Med Cracov; 1979; 21(1):117-30. PubMed ID: 396186 [No Abstract] [Full Text] [Related]
19. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer. Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192 [TBL] [Abstract][Full Text] [Related]
20. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]